Paddock Laboratories, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 1977-01-01
- Employees
- 101
- Market Cap
- -
- Website
- http://www.paddocklabs.com
Clinical Trials
2
Active:0
Completed:2
Trial Phases
1 Phases
Phase 1:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (100.0%)A Relative Bioavailability Study of Moexipril HCl 15 mg Tablets Under Fasting Conditions
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2009-10-09
- Last Posted Date
- 2013-09-26
- Lead Sponsor
- Paddock Laboratories, Inc.
- Target Recruit Count
- 60
- Registration Number
- NCT00992862
- Locations
- 🇺🇸
Novum Pharmaceutical Research Services, Pittsburg, Pennsylvania, United States
A Study to Compare the Relative Bioavailability of Moexipril HCl/Hydrochlorothiazide in Healthy Adult Volunteers Under Fasting Conditions
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- Drug: Uniretic® 15mg/25mg Tablets
- First Posted Date
- 2009-10-06
- Last Posted Date
- 2013-11-25
- Lead Sponsor
- Paddock Laboratories, Inc.
- Target Recruit Count
- 48
- Registration Number
- NCT00990301
- Locations
- 🇺🇸
Novum Pharmaceutical Research Services, Pittsburg, Pennsylvania, United States
News
No news found